|
FAM120AOS expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.74200037412243E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.940499999049E-08 |
| Normal-vs-Stage2 |
9.014400E-04 |
| Normal-vs-Stage3 |
1.41739997516765E-09 |
| Normal-vs-Stage4 |
2.89119839180785E-11 |
| Stage1-vs-Stage2 |
5.212200E-01 |
| Stage1-vs-Stage3 |
1.785870E-02 |
| Stage1-vs-Stage4 |
9.027400E-04 |
| Stage2-vs-Stage3 |
4.863700E-02 |
| Stage2-vs-Stage4 |
4.379900E-03 |
| Stage3-vs-Stage4 |
2.114400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.86259937765499E-11 |
| Normal-vs-AfricanAmerican |
3.485800E-02 |
| Normal-vs-Asian |
4.42649999998768E-06 |
| Caucasian-vs-AfricanAmerican |
4.243000E-01 |
| Caucasian-vs-Asian |
2.425800E-01 |
| AfricanAmerican-vs-Asian |
7.570000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.73890000013211E-07 |
| Normal-vs-Female |
5.33510013944749E-10 |
| Male-vs-Female |
8.378000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.58259999952726E-07 |
| Normal-vs-Age(41-60Yrs) |
1.2530000370603E-09 |
| Normal-vs-Age(61-80Yrs) |
4.24580000046859E-08 |
| Normal-vs-Age(81-100Yrs) |
9.54180000000138E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.392820E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.644400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.048400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.262400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.235450E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.646200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.63959999999986E-05 |
| Classical-VS-Follicular |
1.874590E-01 |
| Classical-VS-Other |
4.785800E-01 |
| Classical-VS-Normal |
2.05880001935554E-09 |
| Tall-VS-Follicular |
4.28370000000733E-05 |
| Tall-VS-Other |
1.481570E-01 |
| Tall-VS-Normal |
1.04871666906092E-12 |
| Follicular-VS-Other |
8.629000E-01 |
| Follicular-VS-Normal |
2.982500E-04 |
| Other-VS-Normal |
1.080210E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.29149999986645E-07 |
| Normal-vs-N1 |
1.06269992805608E-10 |
| N0-vs-N1 |
2.116700E-03 |
|
|
